Global Atropine Sulfate Market Size, Forecast, and Trend Highlights Over 2025-2037
Atropine Sulfate Market size was valued at USD 412.9 million in 2024 and is projected to reach USD 687.8 million by the end of 2037, rising at a CAGR of 4.8% during the forecast period, i.e., 2025 to 2037. In 2025, the industry size of atropine sulfate is estimated at USD 430.4 million.
The atropine sulfate market is witnessing tremendous growth due to its wider applications in ophthalmology, anticholinergics, and emergency medicine. In this regard, according to a WHO report in 2023, myopia is seen in nearly 30.5% of the world’s population, with pediatric cases increasing by 5.2% in a year. These rising instances highly necessitate the demand for ophthalmic atropine formulations across all nations. Additionally, the CDC report in 2023 states that poison control centers report more than 200,000 cases in a year that require anticholinergic treatments. Hence, this is the evidence for a wider scope, highlighting the demand for atropine sulfate globally.
Furthermore, the rising producer price index also demonstrates the higher production values of these products. As per the BLS report in 2024, the PPI for atropine sulfate APIs rose by 8.5% from 2022, similarly, the consumer price index rose by 6.3%, underscoring high distribution costs. Additionally, the business in this sector is driven by research initiatives; in this regard, in 2024, NIH reports a funding for ophthalmic drugs expanded by 9.4% in 2023. Besides, the trade dynamics by USITC in 2023 states that China is a major exporter of APIs, being 40.2%, and the U.S. is the major importer, being 55.3%. Thus, these factors significantly contribute to the market expansion during the forecast timeline.
